Pneumococcal seroepidemiology in Turkey: Implications for vaccine coverage

Erdem H., ŞENER B.

VACCINE, cilt.26, sa.10, ss.1271-1273, 2008 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Kısa Makale
  • Cilt numarası: 26 Sayı: 10
  • Basım Tarihi: 2008
  • Doi Numarası: 10.1016/j.vaccine.2007.12.036
  • Dergi Adı: VACCINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1271-1273
  • Hacettepe Üniversitesi Adresli: Evet

Özet

This paper aims to bring up the most prevalent pneumococcal. serotypes and serogroups detected in recent Turkish studies. The current PCV-7 formulation covers only 37% of IPI in Turkey and if serotypes /groups 4, 6V, 9B, 18C in the current formulation are replaced with 1, 3, 6B and 9A in PCV-7, then the vaccination coverage will increase up to 64%, an improvement that is significant statistically. Similarty, if 11 A, 12F, 1513, 17F and 22F are substituted with 6A, 9A, 9L, 19C and 23B in existing PPV-23, the new formulation wilt increase coverage up to 95% for Turkish population. (C) 2007 Elsevier Ltd. AU rights reserved.